R2PHARMA Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Private

  • Employees
  • 75

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 2

R2PHARMA General Information

Description

Provider of health care technology designed for the nuclear medicine market. The company's technology includes pharmaceuticals injectable medication, medical imaging, and nuclear medicine, enabling doctors, clinics, and hospitals to get access to reliable treatment and diagnosis resulting in a better quality of life.

Contact Information

Formerly Known As
Radiopharmacus
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • Avenida Ipiranga, 6681 Tecnopuc Predio 93
  • Salas 101 e 201 Partenon
  • Porto Alegre, Rio Grande do Sul 90619-900
  • Brazil
+55 (51)
Primary Industry
Other Healthcare Services
Other Industries
Logistics
Diagnostic Equipment
Vertical(s)
Corporate Office
  • Avenida Ipiranga, 6681 Tecnopuc Predio 93
  • Salas 101 e 201 Partenon
  • Porto Alegre, Rio Grande do Sul 90619-900
  • Brazil
+55 (51)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

R2PHARMA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 03-Mar-2020 Completed Generating Revenue
3. Later Stage VC Completed Generating Revenue
2. Seed Round 14-Nov-2011 $1.83M $1.83M Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view R2PHARMA’s complete valuation and funding history, request access »

R2PHARMA Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

R2PHARMA Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Opus Capital Venture Capital Minority
Cietec Accelerator/Incubator Minority
To view R2PHARMA’s complete investors history, request access »

R2PHARMA Investments (1)

R2PHARMA’s most recent deal was a Joint Venture with Telix Innovations Brazil. The deal was made on 17-Mar-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Telix Innovations Brazil 17-Mar-2025 Joint Venture Pharmaceuticals
To view R2PHARMA’s complete investments history, request access »

R2PHARMA FAQs

  • When was R2PHARMA founded?

    R2PHARMA was founded in 2002.

  • Where is R2PHARMA headquartered?

    R2PHARMA is headquartered in Porto Alegre, Brazil.

  • What is the size of R2PHARMA?

    R2PHARMA has 75 total employees.

  • What industry is R2PHARMA in?

    R2PHARMA’s primary industry is Other Healthcare Services.

  • Is R2PHARMA a private or public company?

    R2PHARMA is a Private company.

  • What is R2PHARMA’s current revenue?

    The current revenue for R2PHARMA is .

  • How much funding has R2PHARMA raised over time?

    R2PHARMA has raised $1.83M.

  • Who are R2PHARMA’s investors?

    Opus Capital and Cietec have invested in R2PHARMA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process